AXDX Projected Dividend Yield

Accelerate Diagnostics Inc ( NASDAQ : AXDX )

Accelerate Diagnostics is an in vitro diagnostics company. Co.'s products include the Accelerate Pheno system, which is its in vitro diagnostic platform and is intended for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including Gram-positive and Gram-negative organisms. The Accelerate Pheno system features walk-away automation and consists of a fixed instrument and proprietary single-use test kit. The instrument consists of module(s) connected to a single analysis computer, which allows hospitals to acquire various numbers of modules to address their particular test volume.

20 YEAR PERFORMANCE RESULTS